Simultaneous integrated boost with stereotactic radiotherapy for dominant intraprostatic lesion of localized prostate cancer: a dosimetric planning study

Podobne knjige/članki

• Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts
  od: Goodman, Christopher D., et al.
  Izdano: (2019)
• Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?
  od: Tree, Alison, et al.
  Izdano: (2013)
• Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters
  od: Riches, S F, et al.
  Izdano: (2014)
• Impact of multileaf collimator width on intraprostatic dose painting plans for dominant intraprostatic lesion of prostate cancer
  od: Abe, Eisuke, et al.
  Izdano: (2010)
• Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
  od: Kim, Yeon Joo, et al.
  Izdano: (2020)